Wed.Sep 21, 2022

Dr. Reddy’s Laboratories Ltd.-Walk-In Interview for Freshers On 23rd Sept’ 2022

Pharma Pathway

Reddy’s Laboratories Ltd.-Walk-In Walk-In Interview for Freshers On 23rd Sept’ 2022. Job Description. Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.

Research Results, Replicability, & Retractions

Copyright Clearance Center

As with my earlier post in this series on the overall role of peer review in the scholarly and scientific publishing process, for Peer Review Week 2022 we are reposting our pieces in this series.

Granules India Pvt. Limited-Walk-In Drive for Production -Formulation (OSD) On 23rd Sept’ 2022

Pharma Pathway

Granules India Pvt. Limited-Walk-In Drive for Production -Formulation (OSD) On 23rd Sept’ 2022. Job Description. Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian.

Understanding the Role of Preprints & Postprints & The Version of Record

Copyright Clearance Center

The post Understanding the Role of Preprints & Postprints & The Version of Record appeared first on Copyright Clearance Center. CCC in the News

73

Hetero Labs Limited-Walk-In Interviews for EHS- Process Safety Management/ Process Safety Lab On 24th Sept’ 2022

Pharma Pathway

Hetero Labs Limited-Walk-In Interviews for EHS- Process Safety Management/ Process Safety Lab On 24th Sept’ 2022. Job Description. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

6 Strategies Every Door to Door Sales Rep Should Use

Map My Customers

Even in 2022, there are plenty of solid reasons for salespeople to knock doors: there’s a low overhead cost, you avoid spam filters, there’s less competition, and, by meeting face-to-face, you increase brand recognition.

More Trending

Zydus Lifesciences -Walk-In Interviews for QA/ Production/ QC On 25th Sept’ 2022

Pharma Pathway

Zydus Lifesciences -Walk-In Interviews for QA/ Production/ QC On 25th Sept’ 2022. Job Description. Walk-In Interviews for QA/ Production/QC @ Zydus Lifesciences . We are recruiting for our formulation Manufacturing plant based out of Ahmedabad. Production Department: Officer to Manager: (Production): B.Pharma / M.Pharm/ B.Sc/ M.Sc with 2-16 Years of experience in Production department.

Biogen nets $592M in Boston real estate sale as cost-cutting campaign rolls on

Fierce Pharma

Biogen nets $592M in Boston real estate sale as cost-cutting campaign rolls on. fkansteiner. Wed, 09/21/2022 - 10:20

NICE says yes to BeiGene’s Brukinsa after Scottish nay

Pharma Phorum

BeiGene’s BTK inhibitor Brukinsa (zanubrutinib) has become the first drug in the class to be recommended for routine NHS use in England and Wales to treat Waldenström macroglobulinaemia (WM) – a rare form of non-Hodgkin lymphoma (NHL).

Fennec finally pushes drug to prevent chemotherapy-induced hearing loss across the FDA finish line

Fierce Pharma

Fennec finally pushes drug to prevent chemotherapy-induced hearing loss across the FDA finish line. esagonowsky. Wed, 09/21/2022 - 09:58

Patient centricity is becoming business critical for pharma

Pharma Phorum

New book sets the pharmaceutical industry on a course for bridging the patient centricity optimism gap. Bridging the gulf between patient centricity ambition and reality has never been more important for pharma – luckily, this seemingly insurmountable goal isn’t as far out of reach as many envision.

Avrobio receives FDA rare pediatric disease status for cystinosis therapy

Pharmaceutical Technology

Avrobio has received rare pediatric disease designation from the US Food and Drug Administration (FDA) for its investigational gene therapy, AVR-RD-04, designed to treat cystinosis.

Spectrum, Oncopeptides' oncology drugs have much to overcome heading into FDA adcomm

Fierce Pharma

Spectrum, Oncopeptides' oncology drugs have much to overcome heading into FDA adcomm. kdunleavy. Wed, 09/21/2022 - 06:56

Cell-based therapies set to become major players in the osteoarthritis market

Pharmaceutical Technology

Osteoarthritis (OA) is a slowly progressive joint disease that is a major cause of disability and pain among the elderly, second only to cardiovascular disease.

AHA: Legislative action needed to prevent MA plans from harming Medicare beneficiaries

MedCity News

AHA’s report comes after the U.S. House of Representatives passed the Improving Seniors’ Timely Access to Care Act, which would establish several requirements for the prior authorization process under MA plans. But AHA believes additional action is needed by the government.

Industrial automation hiring levels in the pharmaceutical industry rose in August 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for industrial automation related positions rose in August 2022 compared with the equivalent month last year, with 52% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 49.7%

Blue Cross NC to cover telehealth for behavioral health, primary care, outpatient services

MedCity News

Behavioral health, primary care and outpatient visits accounted for more than 97% of telehealth claims received by Blue Cross NC over the last two years, according to newly released data from the payer. In response, Blue Cross NC will begin covering telehealth for these services.

74

How to Select the Best Candidates for Your Company

Rep-Lite

Medical and pharmaceutical businesses can be challenging ventures. To be successful in these fields, your company should be strong from the ground up. To develop this strength in the foundation of your medical and pharmaceutical company, you must find the best people for the jobs you offer.

Fireside Chat with Dr. Luca Dezzani, VP, US Oncology Medical Affairs at Johnson & Johnson

Impetus Digital

Register for Impetus’ upcoming live webinar on September 28, 2 – 3 PM ET: A Fireside Chat with Fireside Chat with Dr. Luca Dezzani, VP, US Oncology Medical Affairs at Johnson & Johnson. About the webinar.

Vanda Agrees to Settle Over Allegations of False, Misleading Statements

Pharma Leaders

The company has denied any wrongdoing. Compliance Channel Posts

The Future of Data & Information Governance in Life Sciences

PharmExec

Thursday, September 22, 2022 at 11am EDT | 8am PDT | 4pm BST |5pm CEST.

Aragen Life Sciences – Walk-In Interviews for Synthesis R&D (CRO) Dept. On 24th Sept’ 2022

Pharma Pathway

Aragen Life Sciences – Walk-In Interviews for Synthesis R&D (CRO) Dept. On 24th Sept’ 2022. Job Description. Greetings from Aragen Life Sciences (Formerly GVK Bio-Sciences…!!! Aragen Life Sciences is a trusted R&D and manufacturing partner to the global lifesciences industry.

Fireside Chat with Marius Rus, Founder of StressLess | Tully

Impetus Digital

Register for Impetus’ upcoming live webinar on October 4, 9 – 10 AM ET: A Fireside Chat with Marius Rus, Founder of StressLess | Tully. About the webinar.

Hetero Biopharma-Walk-In Interviews for Production/ Quality Control On 23rd Sept’ 2022

Pharma Pathway

Hetero Biopharma-Walk-In Interviews for Production/ Quality Control On 23rd Sept’ 2022. Job Description. Greetings from Hetero Biopharma !!! Walk-In Interviews for Freshers & Experienced in Production/ Quality Control On 23rd Sept’ 2022@ Hetero Biopharma.

Is Your Demand Side Platform (DSP) Ready for the Cookieless Future?

PharmExec

A cookieless future is on the horizon, so marketers across all industries are being forced to rethink their strategies and plan for the future. What does that entail?

Future of work hiring levels in the pharmaceutical industry rose in August 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for future of work related positions rose in August 2022 compared with the equivalent month last year, with 46.9% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 43.7%

Qventus Engages Amendola for Strategic PR and Marketing Services

PharmExec

Award-winning healthcare IT PR agency and care operations automation leaders partner to bring world-class operations to health systems.

AstraZeneca: Redefining Cancer Care

Pharmaceutical Commerce

AZ’s Greg Rossi talks about the company’s oncology activities and his vision for the future of cancer treatment.

Applications of Data Analytics in Bio-Technology

Celeritas

Data Analysis is the next phase in the evolutionary process of data accumulation and sorting. Today, decades’ worth of data may be instantaneously processed to provide industry insights, identify the cause of persistent problems, and provide data-based remedies.

Food 52

Pfizer and CytoReason extend partnership for AI-driven drug discovery

Pharmaceutical Technology

Pfizer and CytoReason have expanded their multi-year collaboration to leverage the latter’s artificial intelligence (AI) technology to discover and develop the former’s drug programmes.

Alnylam receives EU marketing authorisation for hATTR amyloidosis therapy

Pharma Leaders

Amvuttra targets and supresses specific messenger RNA (mRNA) that blocks the wild-type and variant transthyretin (TTR) protein production before it is made. It uses the company’s Enhanced Stabilization.

Industrial automation hiring levels in the pharmaceutical industry rose in August 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for industrial automation related positions rose in August 2022 compared with the equivalent month last year, with 52% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 49.7%

NETRIS Pharma, Orano and CLB partner to develop new radio-conjugates

Pharma Leaders

As part of the partnership deal, the entities will initially plan to conduct a preclinical proof-of-concept efficacy study with the new radio-conjugate targeting Netrin-1, combining Netris’ NP137 with.

Rocket agrees to acquire biotech firm Renovacor

Pharmaceutical Technology

Rocket Pharmaceuticals has entered a definitive agreement for the acquisition of biotechnology firm Renovacor in an all-stock equity deal worth nearly $53m, or $2.60 for each share. Renovacor focuses on offering precision treatments for genetic cardiovascular and mechanistically-related ailments.